09:00 ~ 09:30 |
µî·Ï |
|
09:30 ~ 09:40 |
°³È¸»ç |
±èÁ¾¿ø (´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ ȸÀå) |
09:40 ~ 10:40 |
Session 1: ÃֽŠÀ¯Àü°Ë»ç¿Í ELSI |
|
09:40 ~ 10:10 |
À¯ÀüÀÚ°¡À§ ±â¼úÀ» Ȱ¿ëÇÑ À¯ÀüÀÚ ÆíÁý±â¼úÀÇ ÃÖ±Ù µ¿Çâ |
¹è»ó¼ö (ÇѾç´ë ÈÇаú) |
10:10 ~ 10:40 | À¯ÀüÀÚ°¡À§¸¦ Ȱ¿ëÇÑ À¯ÀüÀÚ ÆíÁý ±â¼ú°ú ¹ýÀû, À±¸®Àû ¹®Á¦ |
½Åµ¿ÀÏ (ÇѰæ´ë
¹ýÇаú) |
10:40 ~ 11:00 |
Coffee
break |
|
11:00
~ 11:30 |
Session II: ºÐÀÚÁø´Ü°Ë»çÀÇ ÃÖ½ÅÁö°ß |
|
11:00
~ 11:30 |
ºÐÀÚÁø´Ü°Ë»ç ÀÓ»óÁø´ÜÁöħ ±Ç°í¾È: Â÷¼¼´ë¿°±â¼¿ºÐ¼®±â¹ýÀ» ÀÌ¿ëÇÑ Ç÷¾×¾ÏÀ¯ÀüÀÚÆÐ³Î¿¡¼ÀÇ Ã¼¼ºÀ¯ÀüÀÚº¯ÀÌ Æò°¡°ËÁõÁöħ |
±èÇýÁø (¸íÁöº´¿ø
Áø´Ü°Ë»çÀÇÇаú) |
11:30
~ 12:50 |
[Ư°] µ¿¹ÝÁø´Ü ¸¶Ä¿ |
|
11:30
~ 12:10 |
BRCA
VUS reclassification in Clinician perspectives |
ÀÓ¸íö (±¹¸³¾Ï¼¾ÅÍ
»êºÎÀΰú) |
12:10
~ 12:50 |
Biomarker
trends in Immuno-Oncology |
¹ÚÀ¯¸² (Çѱ¹¿¥¿¡½ºµð
ÀÇÇкÎ) |
12:50
~ 14:10 |
Áᫎ |
|
14:10
~ 15:50 |
Session III: °Ë»ç½Ç ÀÎÁõ°ú À¯ÀüÀÚ °Ë»ç |
|
14:10
~ 14:30 |
NGS ÀÓ»ó°Ë»ç½Ç °Ë»ç½Ã½ºÅÛ ÀÎÁõ, °ü¸® ±ÔÁ¤ |
°í´ëÇö (¿ï»êÀÇ´ë
Áø´Ü°Ë»çÀÇÇаú) |
14:30
~ 14:50 |
NGS °Ë»ç ºÐ¾ßº° ǰÁú°ü¸®Ã¼°è, ¼÷·Ãµµ, °Ë»ç¼º´É °¡À̵å¶óÀÎ |
ÀåÀÚÇö (³ì½ÊÀÚÁö³ð) |
14:50
~ 15:10 |
À¯Àü°Ë»çÀÇ ±¹³» °Ë»ç½Ç ÀÎÁõ ÇÁ·Î±×·¥ ÀÎÁõ ü°è
¹× Æò°¡ ±âÁØ - Áø´Ü°Ë»çÀÇÇÐÀç´Ü |
ÀÌ¿ìÀÎ (°æÈñÀÇ´ë
Áø´Ü°Ë»çÀÇÇаú) |
15:10
~ 15:30 |
À¯Àü°Ë»çÀÇ ±¹³» °Ë»ç½Ç ÀÎÁõ ÇÁ·Î±×·¥ ÀÎÁõ ü°è
¹× Æò°¡ ±âÁØ - À¯ÀüÀÚ°Ë»çÆò°¡¿ø |
ÀÌ°æ¾Æ (¿¬¼¼ÀÇ´ë
Áø´Ü°Ë»çÀÇÇаú) |
15:30
~ 15:50 |
À¯Àü°Ë»çÀÇ
CLIA ÀÓ»ó°Ë»ç½Ç ÀÎÁõ ¹× °ü¸® ü°è ¹× Æò°¡ ±âÁØ |
¾öÅÂÇö (ÀÎÁ¦ÀÇ´ë
Áø´Ü°Ë»çÀÇÇаú) |
15:50
~ 16:00 |
Coffee
break |
|
16:00
~ 17:00 |
Session IV: À¯ÀüÀÚ °Ë»ç ÇöÇà ±ÔÁ¦ÀÇ ¹®Á¦Á¡°ú °³¼±¹æÇâ |
|
16:00
~ 16:20 | À¯ÀüÀÚ °Ë»ç µ¿ÀÇ ¹× À͸íÈ | ¹Ú°æ¼± (¿¡½ºµðÁö³ë¹Í½º) |
16:20
~ 16:40 | °Ë»ç ´ë»ó¹°ÀÇ Á¦°ø, Æó±â | ¼ÀÚ¿µ (°¡ÃµÀÇ´ë
Áø´Ü°Ë»çÀÇÇаú) |
16:40
~ 17:00 | À¯ÀüÀÚ °Ë»ç ±â°ü ½Å°í ¹× º¯°æ | Çã¹Ì³ª (°Ç´ëÀÇ´ë
Áø´Ü°Ë»çÀÇÇаú) |
17:00
~ 18:00 | Panel Discussion: ±¹³» À¯ÀüÀÚ °Ë»ç ÀÎÁõ Á¦µµ ¹ßÀü ¹æÇâ°ú À¯ÀüÀÚ °Ë»ç ³»½Çȸ¦ À§ÇÑ ¹æ¾È | ÁÂÀå: ±èÁ¾¿ø
(¼º±Õ°üÀÇ´ë) ÆÐ³Î: ¹ßÇ¥ÀÚ ¹× °ü°èÀÚ |